Heron Therapeutics | HRTX - PE Price to Earnings

Stock Price
0.86
Daily Change
-0.03 -3.69%
Monthly
-28.60%
Yearly
-65.17%
Q1 Forecast
0.86

Heron Therapeutics reported 6.46 in PE Price to Earnings for its fiscal quarter ending in December of 2006.





Pe Change Date
ALKERMES 19.54 4.64 Dec/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amarin 91.05 88.3 Jun/2023
ANI Pharmaceuticals 37.99 60.68 Dec/2025
Anika Therapeutics 47.54 27.2 Jun/2024
Eisai 26.63 0.46 Dec/2025
Emergent BioSolutions 14.4 2.25 Sep/2022
Esperion Therapeutics 129.79 129 Dec/2024
GlaxoSmithKline 11.15 0.29 Dec/2025
Heron Therapeutics 6.46 3.23 Dec/2006
Ligand Pharmaceuticals 60.65 17.62 Sep/2025
Merck 13.92 5.08 Dec/2025
Neurocrine Biosciences 835.47 802.2 Dec/2025
Pacira 52.68 23.44 Dec/2025
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
Surmodics 386.18 225.66 Dec/2021
Veracyte 45.3 5.4 Dec/2025
Vertex Pharmaceuticals 26.15 2.22 Dec/2025